Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 3/2016

01-09-2016 | Original Article

CLL: Common Leukemia; Uncommon Presentations

Authors: Deepesh Lad, Pankaj Malhotra, Neelam Varma, Manupdesh Singh Sachdeva, Ashim Das, Radhika Srinivasan, Amanjit Bal, Alka Khadwal, Gaurav Prakash, Vikas Suri, Savita Kumari, Sanjay Jain, Subhash Varma

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2016

Login to get access

Abstract

We report here a series of ten patients with uncommon presentations and associations of chronic lymphocytic leukemia (CLL) not reported hitherto or occasionally reported in literature. The first two cases describe unusual causes of abdominal distension in CLL and unusual sites infiltration by CLL. The next two cases illustrate occurrence of CLL in association with other hematological malignancies. Cases five and six describe unusual infections and their impact on CLL. Cases seven and eight depict associations of rare non-hematological autoimmune conditions with CLL. The last two cases describe transformation at unusual sites. This series of ten cases illustrates how a common leukemia like CLL can present in different forms and how despite so much progress in understanding of this leukemia so little is known of such presentations.
Literature
1.
Kumar N, Varma N, Varma S, Malhotra P (2009) Study of diagnostic and prognostic parameters (including flow cytometry) in chronic lymphoproliferative disorders: the Indian perspective. Anal Quant Cytol Histol 31:296–303PubMed
2.
Da’as N, Polliack A, Cohen Y et al (2001) Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients. Eur J Haematol 67:158–164CrossRefPubMed
3.
Mutluay R, Aki SZ, Erten Y et al (2008) Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia. Clin Nephrol 70:527–531CrossRefPubMed
4.
Aslam N, Nseir NI, Viverett JF, Bastacky SI, Johnson JP (2000) Nephrotic syndrome in chronic lymphocytic leukemia: a paraneoplastic syndrome? Clin Nephrol 54:492–497PubMed
5.
Davis MN, Alloy AM, Chiesa JC, Pecora AA (1990) Chronic lymphocytic leukemia presenting with massive chylous ascites. Am J Gastroenterol 85:593–596PubMed
6.
Yonal I, Nazligul E, Tas G, Agan MR, Yenerel MN, Nalcaci M (2012) A case of chronic lymphocytic leukemia with massive ascites. Rare Tumors 4:13CrossRef
7.
Siddiqui N, Al-Amoudi S, Aleem A, Arafah M, Al-Gwaiz L (2008) Massive ascites as a presenting manifestation of chronic lymphocytic leukemia. World J Gastroenterol 14:3594–3597CrossRefPubMedPubMedCentral
8.
Mamode C, Beauregard P, Langevin S, Mongeau CJ (2000) Chronic lymphoid leukemia complicated with ascites. Can J Gastroenterol 14:181D–184DCrossRefPubMed
9.
Case records of the Massachusetts General Hospital (1983) Weekly clinicopathological exercises. Case 31-1983. Chronic lymphocytic leukemia with the recent development of hepatosplenomegaly and ascites. N Engl J Med 309:297–305CrossRef
10.
May JT, Costanzi JJ (1982) Ascites in chronic leukemia: a case report and review of the literature. Oncology 39:55–58CrossRefPubMed
11.
Mouly S, Cochand-Priollet B, Halimi C, Bergmann JF (1996) Portal hypertension caused by intra-hepatic block in chronic lymphoid leukemia. Presse Med 25:497–498PubMed
12.
Kuse R, Lueb H (1997) Gastrointestinal involvement in patients with chronic lymphocytic leukemia. Leukemia 11:S50–S51PubMed
13.
Malhotra P, Singh M, Kochhar R et al (2005) Leukemia infiltration of bowel in chronic lymphocytic leukemia. Gastrointest Endosc 62:614–615CrossRefPubMed
14.
Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB (2001) Solid tumors after chronic lymphocytic leukemia. Blood 98:1979–1981CrossRefPubMed
15.
Zhou Y, Tang G, Medeiros LJ et al (2012) Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Mod Pathol 25:237–245PubMed
16.
Kumar N, Ahluwalia J, Malhotra P, Sachdeva MU (2013) Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia–accelerated phase: a rare case with review of the literature. Indian J Pathol Microbiol 56:303–305CrossRefPubMed
17.
Salim R, Wang L, Lin K, Clark RE (2002) Chronic lymphocytic leukaemia developing in the course of chronic myeloid leukaemia. Leuk Lymphoma 43:2225–2227CrossRefPubMed
18.
Gargallo P, Cacchione R, Chena C et al (2005) Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events. Cancer Genet Cytogenet 161:74–77CrossRefPubMed
19.
Bhagavathi S, Borromeo V, Desai H, Crisan D (2008) Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia. Ann Clin Lab Sci 38:405–409PubMed
20.
Chang H, Wechalekar A, Li L, Reece D (2004) Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin. Cancer Genet Cytogenet 148:44–48CrossRefPubMed
21.
Brouet JC, Fermand JP, Laurent G et al (1985) The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol 59:55–66CrossRefPubMed
22.
Browett PJ, Leber BF, Coustan-Smith E, Norton JD (1988) Independent clonal origin of coexisting chronic lymphocytic leukaemia and multiple myeloma. Br J Haematol 70:126–127CrossRefPubMed
23.
Fermand JP, James JM, Herait P, Brouet JC (1985) Associated chronic lymphocytic leukemia and multiple myeloma: origin from a single clone. Blood 66:291–293PubMed
24.
Saltman DL, Ross JA, Banks RE, Ross FM, Ford AM, Mackie MJ (1989) Molecular evidence for a single clonal origin in biphenotypic concomitant chronic lymphocytic leukemia and multiple myeloma. Blood 74:2062–2065PubMed
25.
Morrison VA (2010) Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches. Best Pract Res Clin Haematol 23:145–153CrossRefPubMed
26.
Johnston CA, Tang CK, Jiji RM (1979) Histoplasmosis of skin and lymph nodes and chronic lymphocytic leukemia. Arch Dermatol 115:336–337CrossRefPubMed
27.
28.
Skinnider LF, Romanchuk KG (1984) Orbital involvement in chronic lymphocytic leukemia. Can J Ophthalmol 19:142–144PubMed
29.
Ramkissoon YD, Lee RW, Malik R, Hsuan JD, Potts MJ (2008) Bilateral infiltrative disease of the extraocular muscles: a rare clinical presentation of early stage chronic lymphocytic leukemia. Orbit 27:293–295CrossRefPubMed
30.
Del Giudice I, Chiaretti S, Tavolaro S et al (2009) Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases. Blood 114:638–646CrossRefPubMed
31.
Thomas R, Ribeiro I, Shepherd P et al (2002) Spontaneous clinical regression in chronic lymphocytic leukaemia. Br J Haematol 116:341–345CrossRefPubMed
32.
Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ (2013) Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leuk Lymphoma 54:1647–1651CrossRefPubMed
33.
Herishanu Y, Solar I, Ben-Ezra J et al (2012) Complete spontaneous regression of chronic lymphocytic leukemia. J Clin Oncol 30:29CrossRef
34.
D’Arena G, Laurenti L, Coscia M et al (2013) Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: an Italian multicentric survey. Leuk Lymphoma 17:17
35.
Hoption Cann SA, van Netten JP, van Netten C (2003) Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 79:672–680PubMedPubMedCentral
36.
Hamblin TJ (2006) Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 33:230–239CrossRefPubMed
37.
Gonzalez-Gay MA, Blanco R, Gonzalez-Lopez MA (1997) Simultaneous presentation of giant cell arteritis and chronic lymphocytic leukemia. J Rheumatol 24(2):407–408PubMed
38.
Branagan NM, Higgins SP, Halim SA, Le TH (2009) Systemic polyarteritis nodosa mimicking pyoderma gangrenosum in a rare association with small lymphocytic leukaemia/chronic lymphocytic leukaemia. Clin Exp Dermatol 34:1365–2230CrossRef
39.
Lulla P, Bandeali S, Baker K (2011) Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 11:29
40.
Polliack A, Lugassy G (1992) Autoimmunity and auto-immune syndromes associated with and preceding the development of lymphoproliferative disorders. Leukemia 4:152–154
41.
Cerroni L, Zenahlik P, Hofler G, Kaddu S, Smolle J, Kerl H (1996) Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 20:1000–1010CrossRefPubMed
42.
Pavlidis NA, Klouvas G, Tsokos M, Bai M, Moutsopoulos HM (1995) Cutaneous lymphocytic vasculopathy in lymphoproliferative disorders–a paraneoplastic lymphocytic vasculitis of the skin. Leuk Lymphoma 16:477–482CrossRefPubMed
43.
Lopes da Silva R (2012) Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk 12:164–179CrossRefPubMed
44.
Saenz-Frances F, Calvo-Gonzalez C, Reche-Frutos J et al (2007) Bilateral papilledema secondary to chronic lymphocytic leukaemia. Arch Soc Esp Oftalmol 82:303–306CrossRefPubMed
45.
Calvo-Villas JM, Fernandez JA, de la Fuente I, Godoy AC, Mateos MC, Poderos C (2010) Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter’s syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases. Br J Haematol 150(5):618–620. doi:10.​1111/​j.​1365-2141.​2010.​08238.​x Epub 2010 May 13CrossRefPubMed
Metadata
Title
CLL: Common Leukemia; Uncommon Presentations
Authors
Deepesh Lad
Pankaj Malhotra
Neelam Varma
Manupdesh Singh Sachdeva
Ashim Das
Radhika Srinivasan
Amanjit Bal
Alka Khadwal
Gaurav Prakash
Vikas Suri
Savita Kumari
Sanjay Jain
Subhash Varma
Publication date
01-09-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0488-8

Other articles of this Issue 3/2016

Indian Journal of Hematology and Blood Transfusion 3/2016 Go to the issue

Original Article

A Randomized Control Study to Evaluate Effects of Short-term Oral Iron Supplementation in Regular Voluntary Blood Donors

Original Article

Correlation of Notch1/Hes1 Genes Expression Levels in Egyptian Paediatric Patients with Newly Diagnosed and Persistent Primary Immune(Idiopathic) Thrombocytopenic Purpura

Original Article

Cyclosporine Plus Methotrexate or Cyclosporine Plus Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Acute Leukemia Transplant: Comparison of Toxicity, Engraftment Kinetics and Transplant Outcome

Original Article

Evaluation of the Hemostatic Disorders in Adolescent Girls with Menorrhagia: Experiences from a Tertiary Referral Hospital

Original Article

Quantification of Transfusion Recipients at Risk of Receiving Hepatitis B Virus-Contaminated Blood Components: A Korean Study

Original Article

Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits